Contract 75N93021C00042
Via Therapeutics, Llc · Department Of Health And Human Services · September 3, 2021
Via Therapeutics, Llc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 3, 2021 for $300,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Austin, TX. It was awarded under a small business set-aside. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on November 21, 2022.
Contract details
- PIID
- 75N93021C00042
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Austin, TX
- First action
- September 3, 2021
- Latest action
- November 21, 2022
Description
IPP-B
Modification timeline
-
November 21, 2022Mod P00003$0
-
November 17, 2021Mod P00002EO14042 DEVIATION CLAUSE 52.223-99 ENSURING ADEQUATE COVID-19 SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS IS BEING ADDED TO THIS CONTRACT.$0
-
October 28, 2021Mod P00001SBIR 97 VIA THERAPEUTICS$0
-
September 3, 2021Base awardDEVELOPMENT OF LOW-COST, SHELF-STABLE, PATIENT- ADAPTABLE CLOFAZIMINE MINI-TABLETS FOR TREATMENT OF TUBERCULOSIS IN PEDIATRICS$300.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93021C00042?
Contract 75N93021C00042 is a federal contract awarded to Via Therapeutics, Llc by Department Of Health And Human Services on September 3, 2021 for $300,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 3 times since the base award.
Who won contract 75N93021C00042?
Via Therapeutics, Llc won contract 75N93021C00042 from Department Of Health And Human Services.
How much is contract 75N93021C00042 worth?
Contract 75N93021C00042 has obligated $300,000 to date.